Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-11-24
1994-06-21
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549363, A61K 31335, C07D49308
Patent
active
053228553
ABSTRACT:
Zaragozic acids isolated from a culture of MF5465 have been subjected to photoreaction, then derivatized at the 4-keto position. The resulting derivatives are active as squalene synthetase inhibitors and are useful in the treatment of hypercholesterolemia.
REFERENCES:
patent: 5026554 (1991-06-01), Bartizal et al.
patent: 5096963 (1992-03-01), Blain
patent: 5102907 (1992-04-01), Bergstrom
patent: 5132320 (1992-07-01), Bergstrom et al.
Cleary, "Further Synthetic Studies . . . ", Syn. Commun., vol. 19(546), pp. 737-744, 1989.
Garlaschelli et al., "Anhydrons Lanthanum Trichloride, . . . ", Tet. Let., vol. 31(40), pp. 5815-5816, 1990.
Singh, "Transannular Cyclization Reactions . . . ", J. Org. Chem., vol. 44(5), pp. 843-846, 1979.
Baxter et al., "Squalestatin 1, . . . ", J. Biol. Chem., vol. 267(17), pp. 11705-11708, 1992.
Dawson et al., "The Squalestatins, . . . I. Taxonomy, . . . ", J. Antibiotics, vol. 45(5), pp 639-647, 1992.
Sidebottom et al., "The Squalestatins, . . . II. Structure Elucidation", J. Antibiotics, vol. 45(5), pp. 648-658, 1992.
Vercek et al. "Neighboring Group Interaction . . . ", J. Org. Chem., vol. 44(10), pp. 1695-1699, 1979.
Arison Byron H.
Doss George A.
Treiber Laszlo R.
Cintins Marianne M.
Hydorn Michael B.
Merck & Co. , Inc.
Meredith Roy D.
Tribble Jack L.
LandOfFree
Cholesterol lowering compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cholesterol lowering compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cholesterol lowering compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2220858